Trials / Completed
CompletedNCT00898417
Biomarker Study of Blood Samples From Patients With Non-Small Cell Lung Cancer Treated With Carboplatin and Paclitaxel With or Without Bevacizumab
Development of a Serum Proteomic Classifier for the Prediction of Benefit From Bevacizumab in Combination With Carboplatin and Paclitaxel
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 90 (actual)
- Sponsor
- ECOG-ACRIN Cancer Research Group · Network
- Sex
- All
- Age
- 18 Years – 120 Years
- Healthy volunteers
- Not accepted
Summary
RATIONALE: Studying samples of blood in the laboratory from patients undergoing treatment for non-small cell lung cancer may help doctors predict how patients will respond to treatment. PURPOSE: This laboratory study is looking at proteomic patterns in stored blood samples from patients undergoing treatment for non-small cell lung cancer.
Detailed description
OBJECTIVES: Primary * To develop a serum proteomic classifier using matrix-assisted laser-desorption/ionization time-of-flight mass spectrometry analysis of blood samples from patients with non-squamous cell non-small cell lung cancer to predict benefit, in terms of survival and time to progression, from treatment with bevacizumab in combination with carboplatin and paclitaxel. Secondary * To better quantitate candidate biomarkers by using more advanced mass spectrometric technologies, including multiple-reaction monitoring and heavy-labeled peptides. OUTLINE: Previously collected pre-treatment samples of serum or plasma are randomly selected from patients enrolled on protocol ECOG-4599 (i.e., 60 from the bevacizumab arm and 30 from the control arm). Samples are analyzed by matrix-assisted laser-desorption/ionization time-of-flight mass spectrometry to identify patterns from protein spectra that correlate with patient survival.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | bevacizumab | |
| DRUG | carboplatin | |
| DRUG | paclitaxel | |
| GENETIC | proteomic profiling | |
| OTHER | laboratory biomarker analysis | |
| OTHER | matrix-assisted laser desorption/ionization time of flight mass spectrometry |
Timeline
- Start date
- 2008-03-14
- Primary completion
- 2008-04-14
- Completion
- 2008-04-14
- First posted
- 2009-05-12
- Last updated
- 2017-05-19
Source: ClinicalTrials.gov record NCT00898417. Inclusion in this directory is not an endorsement.